Selecting and Optimizing Insulin Therapy
Endocrinology
Curriculum:
New Directions in Insulin: Options & Strategies
New Directions in Insulin: Options & Strategies
Credits:
1 ACPE 1 AMA PRA Category 1 Credit(s) ™
1 ACPE 1 AMA PRA Category 1 Credit(s) ™
Launch Date:
January 06, 2016
January 06, 2016
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Primary care physicians; nurses; physician assistants; and other clinicians who treat patients with type 2 diabetes
Relevant Terms:
Type 2 diabetes; insulin; GLP-1 receptor agonists; hypoglycemia; treatment intensification
Kathleen Dungan, MD, MPH
Kathleen Dungan, MD, MPH
Associate Professor, Associate Division Director for Clinical Services
Division of Endocrinology, Diabetes and Metabolism
The Ohio State University
Columbus, Ohio
Bio
Dr. Dungan currently serves as the Associate director of Clinical Services for the OSU Division of Endocrinology, Diabetes & Metabolism and Director of the Endocrine clinical trials unit. She also serves on the division CME committee and on the planning committee for the Endocrine Society Clinical Endocrine Update. Dr. Dungan has published a variety of formats on clinical therapeutics of diabetes, type 1 and type 2. She has a clinical practice in ambulatory and inpatient settings.Jane Jeffrie-Seley, DNP, MSN, MPH, GNP, BC-ADM, CDE, CCTC, FAAN
Jane Jeffrie-Seley, DNP, MSN, MPH, GNP, BC-ADM, CDE, CCTC, FAAN
Diabetes Nurse Practitioner
Division of Endocrinology, Diabetes & Metabolism
New York-Presbyterian Hospital
Weill Cornell Medicine
New York, New York
Bio
Dr. Seley is a Diabetes Nurse Practitioner and Certified Diabetes Educator in the Division of Endocrinology, Diabetes & Metabolism at NewYork-Presbyterian Hospital/ Weill Cornell Medical Center in New York City. She was recently elected to the 2016-2018 Board of Directors of the American Association of Diabetes Educators (AADE) and served on the 2012-2014 AADE board and numerous committees for AADE and the American Diabetes Association (ADA). Jane is contributing editor and column coordinator of the Diabetes Under Control column in the American Journal of Nursing, co-author of the Endocrine Society Guidelines for the management of hyperglycemia in the non-critical care setting, guest editor of the 2014 inpatient management focused issue of ADA's Diabetes Spectrum and has chapters in three recent ADA books. Jane is an active speaker and author committed to both patient and professional diabetes education and the advancement of diabetes technology as a tool to assist people living with diabetes and the clinicians that care for them.| 1. | Accurately evaluate patients with T2DM to determine when insulin initiation/intensification may be necessary | 2. | Compare emerging insulin options with currently available therapies and discuss therapeutic choices with patients |
| 3. | Identify patients who may require insulin intensification to achieve improved prandial control | 4. | Develop strategies to create effective clinician/patient partnerships to maximize effective T2DM management |
| 1. | Accurately evaluate patients with T2DM to determine when insulin initiation/intensification may be necessary |
| 2. | Compare emerging insulin options with currently available therapies and discuss therapeutic choices with patients |
| 3. | Identify patients who may require insulin intensification to achieve improved prandial control |
| 4. | Develop strategies to create effective clinician/patient partnerships to maximize effective T2DM management |
Release Date: January 6, 2016
Expiration Date: January 5, 2018
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and DKBMed. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Estimated time to complete this activity 1 hour. It is estimated to take 1.5 hours of the participant's time to complete the entire series (2 activities).
Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - 0809-9999-16-186-H01-P)
Type of Activity
Application
Target Audience
The target audience includes physicians, nurse practitioners, physician assistants, allied health care providers, and pharmacists.
Educational Support
This educational activity is supported by an independent educational grant from Novo Nordisk Inc.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Dr. Kathleen Dungan, has received the royalty from Up-to-Date®, and consulting fees from Eli Lilly and Company and GlaxoSmithKline. She has contracted research from Novo Nordisk Inc, GlaxoSmithKline, Sanofi-Aventis, Merck & Co., Inc., Astra-Zeneca, and has performed other CME services for Astra-Zeneca.
Dr. Jane Jeffrie Seley, has no real or apparent conflict to report.
Dr. Kathleen Dungan, has received the royalty from Up-to-Date®, and consulting fees from Eli Lilly and Company and GlaxoSmithKline. She has contracted research from Novo Nordisk Inc, GlaxoSmithKline, Sanofi-Aventis, Merck & Co., Inc., Astra-Zeneca, and has performed other CME services for Astra-Zeneca.
Dr. Jane Jeffrie Seley, has no real or apparent conflict to report.
Planners
The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following DKB planners and managers, Dean Beals, Stan Pogroszewski, and Rachel Deerr, hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interest related to the content of the activity of any amount during the past 12 months.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Media
Internet
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation and Request for Credit
Please review the program in its entirety and successfully complete the posttest with at least 70% to receive a certificate of credit.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation and Request for Credit
Please review the program in its entirety and successfully complete the posttest with at least 70% to receive a certificate of credit.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above |
